Anisotropic mechanotransductive tissue constructs via brush-assisted bioprinting of microfiber-reinforced composite bioinks.
Mohan P., Choi B., Yoon D., Kim G.
Animal Study on Cardiovascular Disease, published in Bioact Mater (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Bioact Mater (2025)
- Country
- China
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41532008
- PMCID
- PMC12794435
- DOI
- 10.1016/j.bioactmat.2025.12.017
Abstract (original English)
Engineering aligned musculoskeletal and cardiac tissues remains a key challenge due to the lack of mechanical cues in conventional bioinks. Here, we present a synergistic strategy combining fiber-reinforced collagen bioinks with a brush-assisted bioprinting (BAB) process to fabricate highly organized, functional tissue constructs. The bioink incorporates straight and coiled poly(ε-caprolactone) (PCL) microfibers to deliver spatially defined biophysical guidance, while the BAB process applies directional and homogeneous shear stress to align both fibers and cells during printing. This integrated approach enhances cytoskeletal organization and activates mechanosensitive pathways, including YAP/TAZ and PIEZO1 , promoting myogenic differentiation. In vitro , printed bioconstructs using C2C12 and H9C2 exhibited improved cell alignment, gene expression, and structural maturation. In a murine volumetric muscle loss (VML) model, BAB-fabricated human adipose-stem cell (hASC)-laden constructs restored muscle mass and function more effectively than control, with the coiled fiber group showing the significantly meaningful levels of muscle regeneration, reduced fibrosis, and human cell integration. Based on these results, this work can demonstrate a new platform for fabricating anisotropic tissue constructs and offer significant potential for translational applications in regenerative medic
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Factor XII-A New Therapeutic Target? A Systematic Review
Systematic Review on Cardiovascular Disease, Neuroinflammation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci1 citations - Level AMeta-analysisEurope PMC
Can cell-based therapies bridge the gap between research and reality in the treatment of myocarditis? A systematic review and meta-analysis
Meta-analysis on Cardiovascular Disease, published in Regen Ther (2026) — summary generated from the PubMed abstract.
- 2026
Regen Ther - Level AMeta-analysisEurope PMC
Efficacy and safety of stem cell therapy for myocardial infarction and heart failure: an updated systematic review and meta-analysis of randomized controlled trials
Meta-analysis with a reported sample of 3345 on Cardiovascular Disease, Stroke Research, published in Syst Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 3345
Syst Rev - Level AMeta-analysisEurope PMC
Orally derived mesenchymal stem cells in the treatment of vascular diseases: a systematic review and meta-analysis
Meta-analysis on Cardiovascular Disease, published in Sci Rep (2026) — summary generated from the PubMed abstract.
- 2026
Sci Rep - Level ASystematic ReviewEurope PMC
From Preservation to Repair: A Systematic Review of Therapeutic Organ Rehabilitation During Normothermic Ex Vivo Machine Perfusion
Systematic Review with a reported sample of 12 on Cardiovascular Disease, Immune Modulation, published in Transplant Direct (2026) — summary generated from the PubMed abstract.
- 2026
- n = 12
Transplant Direct - Level AMeta-analysisEurope PMC
Safety and Efficacy of Transendocardial Stem Cells Therapy in Chronic Ischemic Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Meta-analysis on Cardiovascular Disease, Stroke Research, published in Curr Cardiol Rev (2025) — summary generated from the PubMed abstract.
- 2025
Curr Cardiol Rev